WARRANT AGENCY AGREEMENTWarrant Agency Agreement • August 25th, 2015 • Mabvax Therapeutics Holdings, Inc. • Pharmaceutical preparations • Delaware
WARRANT AGENCY AGREEMENT (this “Warrant Agreement”) made as of [·], 2015 (the “Issuance Date”), between MabVax Therapeutics Holdings, Inc., a Delaware corporation, with offices at 11588 Sorrento Valley Road, Suite 20, San Diego, CA 92121 (the “Company”), and Equity Stock Transfer LLC, a Nevada limited liability company, with offices at 237 W 37th Street, New York, NY 10018, (“Warrant Agent”).
Shares of Common Stock and [_____________] Warrants to Purchase an Aggregate of [_____________] Shares of Common Stock MABVAX THERAPEUTICS HOLDINGS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • August 25th, 2015 • Mabvax Therapeutics Holdings, Inc. • Pharmaceutical preparations • New York
MabVax Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained in this agreement (this “Agreement”), to sell to you and the other underwriters named on Schedule I hereto (collectively, the “Underwriters”), for whom you are acting as Representative (the “Representative”), an aggregate of [___________] shares (the “Firm Shares”) of the Company’s common stock, $0.01 par value per share (the “Common Stock”). For every two Firm Shares issued and sold by the Company, the Company shall issue and sell to the several Underwriters one warrant to purchase one share of Common Stock at an initial exercise price of $[___] per share ([__]% of the public offering price per Firm Share in the offering), subject to adjustment as provided therein (each, a “Warrant” and collectively, the “Warrants”), or an aggregate of [________] Warrants to purchase an aggregate of [______] shares of Common Stock (the “Firm Warrants” and together with th
FORM OF PROPOSED] LEASE by and between AGP SORRENTO BUSINESS COMPLEX, L.P., a Delaware limited partnership and MABVAX THERAPEUTICS HOLDINGS, INC., a Delaware corporationLease • August 25th, 2015 • Mabvax Therapeutics Holdings, Inc. • Pharmaceutical preparations
THIS LEASE (this "Lease") is entered into effective as of the ____ day of, August, 2015 (the "Execution Date"), by and between AGP SORRENTO BUSINESS COMPLEX, L.P., a Delaware limited partnership ("Landlord"), and MABVAX THERAPEUTICS HOLDINGS, INC., a Delaware corporation ("Tenant").
